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a b s t r a c t
Big efforts have been dedicated up to now to identify novel targets for cancer treatment. The peculiar
biophysical profile and the atypical ionic channels activity shown by diverse types of human cancers
suggest that ion channels may be possible targets in cancer therapy. Earlier studies have shown that
melatonin exerts an oncostatic action on different tumors. In particular, it was shown that melatonin was
able to inhibit growth/viability and proliferation, to reduce the invasiveness and metastatic properties of
human estrogen-sensitive breast adenocarcinoma MCF-7 cell line cultured in growth medium, with
substantial impairments of epidermal growth factor (EGF) and Notch-1-mediated signaling. The purpose
of this work was to evaluate on MCF-7 cells the possible effects of melatonin on the biophysical features
known to have a role in proliferation and differentiation, by using the patch-clamp technique. Our results
show that in cells cultured in growth as well as in differentiation medium melatonin caused a
hyperpolarization of resting membrane potential paralleled by significant changes of the inward Ca2þ
currents (T- and L-type), outward delayed rectifier Kþ currents and cell capacitance. All these effects are
involved in MCF-7 growth and differentiation. These findings strongly suggest that melatonin, acting as a
modulator of different voltage-dependent ion channels, might be considered a new promising tool for
specifically disrupting cell viability and differentiation pathways in tumour cells with possible beneficial
effects on cancer therapy.
& 2015 Elsevier B.V. All rights reserved.
1. Introduction
Conventional chemotherapy is not always successful and usually
accompanied by systemic toxicity and detrimental side effects.
Thus, growing attempts are made to identify novel targets for
cancer therapy.
The diverse types of human cancers may show a peculiar
biophysical profile with an atypical ion channels activity (Abdul
et al., 2003; Arcangeli et al., 2009). In such perspective, it might be
worth to better characterize this issue with the aim of designing
efficient ionic channel inhibitors/modulators that may potentially
affect cancer therapy. Functional relationship exists between resting
membrane potential, Kþ channel type expression and cell functions
such as proliferation and differentiation (Asher et al., 2010; Cos and
Sánchez-Barceló, 2003; Enomoto et al., 1986; Wang, 2004). Resting
membrane potential is typically more depolarized in undifferentiated
respect to differentiated cells (O’Grady and Lee, 2005; Pardo, 2004)
and in cancer cells respect to terminally differentiated cells
(Kunzelmann, 2005). Of interest, resting membrane potential and
the type and amount of Kþ and Ca2þ currents change during both
cell cycle and differentiation (Blackiston et al., 2009; Sundelacruz
et al., 2009) and are atypically modified in cancer cells (Becchetti,
2011; Bielanska et al., 2009; Haren et al., 2010; Lang et al., 2003;
Ohkubo and Yamazaki, 2012; Ouadid-Ahidouch and Ahidouch, 2008).
By multidisciplinary approach, it was demonstrated on MCF-7
cell line (Margheri et al., 2012) that growth/viability and prolifera-
tion is significantly reduced by the treatment with melatonin,
the hormone mostly produced by the pineal gland (Jablonska
et al., 2013).
Moreover, preclinical in vitro and in vivo studies and clinical
trials showed that melatonin was able to exert an oncostatic action
on different tumors (Girgert et al., 2009; Hill et al., 2009, 2011a,b;
Jung and Ahmad, 2006; Sánchez-Barceló et al., 2012; Srinivasan
et al., 2008), to increase the efficacy of chemotherapy when used
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in adjuvant settings and to decrease the side effects (Vijayalaxmi
et al., 2002). Since proliferation and differentiation are typical of
any cell system and are carefully regulated in the course of
physiological development and life cycle, tumor evolution must
imply a deregulation of their morphofunctional features.
In the present study, we evaluated the electrophysiological
properties and the effects of melatonin on MCF-7 cells cultured in
either growth or differentiation medium focusing our attention on
ion channels as possible novel targets involved in cancer patho-
physiology. In particular, by electrophysiological technique, we
evaluated the action of melatonin on resting membrane potential
and on voltage-dependent ionic channels known to play a role in
proliferation (Baglioni et al., 2012; Bertolesi et al., 2002; Currò,
2014; Enomoto et al., 1986; Gamper et al., 2002; Girgert et al.,
2009; Grant et al., 2009; Gray et al., 2004; Haren et al., 2010;
Kunzelmann, 2005).
The rationale for this research originates from the evidence
that several ionic channels have a key role in proliferation and
differentiation and can be therefore considered as new targets for
cancer therapy (Arcangeli et al., 2009).
2. Materials and methods
2.1. Cell culture and treatments
Human hormone-sensitive breast adenocarcinoma cell line
MCF-7 was obtained from American Type Culture Collection
(ATCC, Manassas, VA, USA). The cells were cultured as pre-
viously described (Margheri et al., 2012). Briefly, cells were
cultured in Dulbecco's modified Eagle's medium (DMEM, Sigma,
Milan, Italy) supplemented with 10% Fetal Bovine Serum (FBS,
Sigma), 100 U/mL penicillin–streptomycin and 1% L-glutamine
200 mM (Sigma) in a humidified 5% CO2 atmosphere at 37 1C.
This medium was suitable to allow cells growth/proliferation. In
all the experiments melatonin 100 mM (Sigma) was used. This
dose was proved to be the most effective to reduce cell viability
and proliferation in this experimental model (Margheri et al.,
2012). MCF-7 cells were cultured in growth medium in the
presence of 100 mM melatonin for 24, 48, 72 h. In parallel
experiments, the cells were cultured for 72 h in growth medium
in the presence of melatonin and/or the following channel
blockers (Sigma): nifedipine (10 mM) and NiCl2 (50 mM) for
L- and T-type Ca2þ channels; α-dendrotoxin, α-DTX (10 nM)
for K(V), iberiotoxin, IbTx (100 nM) for BK and chromanol, Chr
(50 mM) for Ks channels. The treatments lasted up to 72 h and
the media were daily replaced. In other experiments the cells
were cultured for 72 h in differentiation medium (supplemen-
ted with 2% FBS) and treated with channel blockers as above
described.
2.2. Cell growth/viability assay (MTS)
Cell growth/viability was evaluated by 3-(4.5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium
(MTS) assay (Promega, Madison, WI, USA). MCF-7 cells were plated
into 96-multiwell-plates and then treated with melatonin 100 mM
and/or the above-mentioned channel blockers for 72 h. Then, the
cells were shifted in 100 ml of fresh medium phenol red-free and
20 ml of MTS test solution was added to each well. After 4 h of
incubation, the color reaction was measured using a multi-well
scanning spectrophotometer (Enzyme-Linked ImmunoSorbent
Assay-ELISA- reader) (Amersham, Pharmacia Biotech, Cambridge,
UK) at a wavelength of 490 nm. The values were expressed as
mean7S.D. obtained from five independent experiments carried
out in triplicates.
In some experiments MCF-7 were treated with melatonin for
72 h in growth medium and, in a parallel set of experiments, in
differentiation medium and treated with different channel
blockers.
2.3. Confocal immunofluorescence
To detect proliferation activity, untreated and treated MCF-7
cells grown on glass coverslips were fixed with 0.5% buffered
paraformaldehyde for 10 min at room temperature. After permea-
bilization with cold acetone for 3 min, the fixed cells were blocked
with 0.5% bovine serum albumin (BSA; Sigma) and 3% glycerol in
PBS for 20 min and then immunostained with rabbit polyclonal
anti-Ki-67 (1:100; Abcam, Cambridge, UK). The immunoreaction
was revealed by incubation with specific anti-rabbit Alexa Fluor
488-conjugated IgG (1:200; Molecular Probes, Eugene, OR, USA),
for 1 h at room temperature. After washing in PBS, the sections
were mounted with an anti-fade mounting medium (Biomeda Gel
mount, Electron Microscopy Sciences, Foster City, CA, USA). A
negative control was performed by replacing the primary antibody
with non-immune mouse serum. Sections were examined with a
Leica TCS SP5 confocal laser scanning microscope (Leica Micro-
system, Mannheim, DE) equipped with a HeNe/Argon laser source
for fluorescence measurements. Fluorescence was collected using
a Leica PlanApo x63 oil-immersion objective. Optical sections
(10241024 pixels) at intervals of 0.8 mm were obtained and
superimposed to create a single composite image. When needed, a
single optical fluorescent section and DIC images were merged to
view the precise distribution of the immunostaining. Quantifica-
tion of Ki-67 expression was performed on digitized images by
counting the number of positive cells over the total cell number.
2.4. Confocal analysis of intracellular Ca2þ concentration
The analysis of [Ca2þ]i was performed as previously reported
(Formigli et al., 2002). Briefly, to reveal the resting intracellular
calcium concentration in MCF-7 cells in the absence or presence of
melatonin (100 μM), 2104 cells were plated on glass cover-
slips and incubated at 37 1C for 10 min in DMEM with Fluo
3-acetoxymethyl ester (Molecular Probes) as fluorescent Ca2þ
indicator at a final concentration of 10 μM and 0.1% anhydrous
dimethyl sulfoxide and Pluronic F-127 (0.01% wt/vol) as dispersing
agent (Molecular Probes). After being washed, the cells were
placed in open slide flow-loading chambers mounted on the stage
of the confocal laser scanning microscope. Optical sections
(10241024 pixels) at intervals of 0.8 mm were obtained. A
variable number of cells ranging from 15 to 30 were analysed for
each cell preparation. Multiple regions of interest (ROIs) of 25 μm2
were selected within the cells to monitor Ca2þ signals, and outside
the cells as baseline. Fluorescence signals were expressed as
fractional changes above the resting baseline, ΔF/F, where F was
the averaged baseline fluorescence and ΔF represented the fluor-
escence changes from the baseline.
2.5. Electrophysiological experiments
The electrophysiological characteristics of different voltage-
gated ionic channels of cultured MCF-7 were investigated on glass
coverslip-adherent single cells at room temperature (20–23 1C) by
the whole-cell patch-clamp technique (Baglioni et al., 2009;
Margheri et al., 2012); both voltage-clamp and current-clamp
modes were used.
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2.5.1. Solutions
Experiments performed to evaluate the membrane passive
properties (membrane conductance, Gm, and cell capacitance,
Cm) and resting membrane potential were carried out in Normal
Tyrode bath solution with the following composition (mM): NaCl
140, KCl 5.4, CaCl2 1.5, MgCl2 1.2, glucose 5.5, and HEPES/NaOH 5
(pH 7.35). For Kþ and Ca2þ currents records we used a modified
Normal Tyrode solution with different specific channels blockers
added: TTX (1 μM) to block voltage activated Naþ channels,
4-aminopyridine (2 mM) to block the 4-aminopyridine sensitive-
transient outward potassium current (Ito) and BaCl2 (0.4 mM) to
block the inward rectifier Kþ current, IKir. To record only Kþ
currents without any inward Ca2þ current contamination we
added nifedipine (10 mM) and Ni2þ (50 mM) to block L- and
T-type Ca2þ current, respectively or Cd2þ (0.8 mM) to block both
the types. To evaluate the presence of the voltage- and Ca2þ-
dependent delayed-rectifier iberiotoxin-sensitive Kþ current (IBK),
of the slowly activating chromanol-sensitive Kþ current (IKs) and
of the fast activating α-dendrotoxin-sensitive Kþ current, IK(V), we
performed a pharmacological dissection as previously reported
(Baglioni et al., 2012). Briefly, we first applied the stimulation
protocol in control condition to record the total Kþ current traces
(IK,tot). This was the result of the amount of all the three Kþ
currents mentioned above plus a residual current (Ix), due to other
currents that were not eliminated or not completely blocked by
our procedure. After that, we generally applied the selective drugs
in the following sequence: Chr, IbTx and α-DTX to block IKs, IBK and
IK(V), respectively. After Chr application, the remaining currents
were IBKþ IK(V)þ Ix; after Chr and IbTx application, IK(V)þ Ix
remained and, finally, after Chr, IbTx and α-DTX addition, only Ix
remained. Subsequently, the current traces obtained in the pre-
sence of Chr were subtracted from those recorded in control
condition to obtain the slowly activating IKs current; then, the
traces recorded in the presence of Chr and IbTx were subtracted
from traces in Chr to assess the IBK current time course. Finally, the
traces recorded in the presence of Chr, IbTx and α-DTX were
subtracted from Chr and IbTx traces to observe the fast activating
IK(V) time course.
Experiments aimed to record only Ca2þ currents were per-
formed in a high-TEA solution (Naþ- and Kþ-free) (mM): CaCl2 10,
TEABr 145 and HEPES 10.
Patch pipettes had tip resistances of 3–7 MΩ. For Kþ currents
records, they were filled with a solution containing (mM): KCl 130,
NaH2PO4 10, CaCl2 0.2, EGTA 1, MgATP 5 and HEPES 10. pH was set
to 7.2 with KOH. For Ca2þ currents records, the same kind of
electrodes were filled with (mM): 150 CsBr, 5 MgCl2, 10 EGTA and
10 HEPES. pH was set to 7.2 with CsOH.
2.5.2. Stimulation protocols
The Ca2þ currents activation pulse protocol consisted of 1-s
long step pulses applied to cells held at 80 mV and ranging from
70 to 50 mV in 10 mV increments. The protocol used an interval
of 20 s between stimulating episodes for recovery. The steady-
state inactivation was studied by a two-pulse protocol with 1-s
pre-pulses to different voltages followed, after 500 ms, by 1-s test
pulse fixed to 20 or 0 mV for T- and L-type Ca2þ currents,
respectively. Again, in the two-pulse protocol, we used an interval
of 10 s between stimulating episodes for recovery. All the activa-
tion and inactivation protocols were repeated twice. The steady-
state ionic current activation was evaluated by: Ia(V)¼Gmax
(VVrev)/{1þexp[(VaV)/ka]} and steady-state inactivation by:
Ih(V)¼ I/{1þexp[(VhV)/kh]}, where Gmax is the maximal con-
ductance for the Ia; Vrev is the apparent reversal potential; Va and
Vh are the potentials eliciting the half-maximal activation
and inactivation values, respectively; ka and kh are the steepness
factors. The passive properties parameters were evaluated as
previously described (Baglioni et al., 2009). Linear leak and
capacitive currents were canceled on-line using the P/4 procedure.
This procedure also minimized the not-voltage dependent cur-
rents such as those flowing through intermediate-conductance
Ca2þ-activated Kþ channels, IKCa (Haren et al., 2010), and stretch
activated channels (Formigli et al., 2007; Sbrana et al., 2008).
The total Kþ current (IK,tot) flowing through delayed rectifier
channels was recorded in modified Normal Tyrode solution,
evoked in voltage clamp mode by applying voltage steps in
10 mV increments from a holding potential (HP) of 80 mV.
Moreover, to minimize Ca2þ currents that could counterbalance
the outward Kþ currents we used an HP of 60 and 40 mV or,
in some experiments, nifedipine and Ni2þ . To analyse the Ca2þ-
and voltage- dependent Kþ current, IBK, two procedures were
used. First, the IBK voltage-dependence in the MCF-7 cells was
investigated as reported in Margheri et al. (2012). Then, the Ca2þ-
dependence of IBK was studied using a double-pulse protocol
according to Prakriya and Lingle (1999) in modified Normal Tyrode
solution with α-DTX (10 nM) and Chr (50 mM) added to block IK(V)
and IKs. In brief, the voltage command consisted of a double-pulse
protocol with a test potential of 400 ms to 70 mV preceded by a
pre-pulse to 0 mV. This test pulse to 70 mV allowed the IBK
occurrence without Ca2þ influx or with just a reduced one, since
this voltage value is close to the Ca2þ reversal potential. The pre-
pulse to 0 mV was used to activate the maximal inward Ca2þ
currents. In order to evaluate the IBK Ca2þ-dependence we
increased the Ca2þ influx by increasing the pre-pulse duration.
This was increased from 5 to 25 ms in 5-ms increments and from
25 to 95 ms in 10-ms increments.
The Cm value was considered as an index of the cell surface area
assuming that membrane-specific capacitance is constant at 1 μF/cm2.
The total current amplitude (Itot) of each type of channel investigated
was used as an index of the total channel functionality, whereas
current values normalized to cell linear capacitance (I/Cm) was referred
to as current density. Current records were considered reliable when
the rundown of Cm, resting membrane potential or the studied ionic
current size was less than 5%.
2.6. Statistical analysis
Mathematical and statistical analysis of electrophysiological
data was performed by pClamp9 (Axon Instruments) and Sigma-
Plot (Jandel Scientific). The Kolmogorov–Smirnov test was used to
verify normal distribution of the data. ANOVA was applied for
multiple comparisons, followed by the Dunnett's post-hoc test.
The number of cells used is indicated as n in figures and table
legends. Data are expressed as the mean7S.E.M. Statistical sig-
nificance was determined by one-way ANOVA and Newman–Keuls
multiple comparison for analysis of cell growth/viability assay or
Student's t test. A P valuer0.05 was considered significant.
Calculations were performed using GraphPad Prism software
(GraphPad, San Diego, CA, USA).
3. Results
3.1. Melatonin reduces Ca2þ currents in MCF-7 cells
To estimate the effect of melatonin on ion currents known to have
a role in cell proliferation, we firstly focused on T- and L-type Ca2þ
currents. Since several studies demonstrated that human mammary
cancer cell lines express voltage-dependent Ca2þ channels (Bertolesi
et al., 2002; Ohkubo and Yamazaki, 2012), we intended to evaluate
the effects of melatonin on voltage-dependent Ca2þ currents in
MCF-7 cells cultured in growth medium. In control conditions we
R. Squecco et al. / European Journal of Pharmacology 758 (2015) 40–5242
could observe a low voltage-activated inward transient current
starting from 60 mV up to 40 mV. For further depolarizing
voltage steps a slowly activating and decaying current superimposed
on such a transient current (Fig. 1Aa). When nifedipine was added to
the bath solution, only the transient response was recorded (Fig. 1Ba).
This latter was no longer detectable when Ni2þ was added in the
recording chamber (not shown), so we assumed it was ICa,T. Since no
Ca2þ currents were observed in the presence of Ni2þ and nifedipine,
we reasonably suppose that the only type of high voltage activated
Ca2þ channel expressed on MCF-7 cells was the L-type one. Thus, the
related L-type Ca2þ current was obtained by subtracting ICa,T from
the total ICa current (Fig. 1Bb). The resulting L-type Ca2þ current, ICa,L,
generated by a 0 mV pulse peaked at about 20 ms and after an early
fast inactivation with a time constant of about 20 ms, it was followed
by a slowly decaying phase after about 200–250 ms having a time
constant of about 280 ms.
Melatonin treatment was able to clearly reduce ICa,tot size
(Fig. 1Ab). In particular, we observed the decrease in amplitude of
both Ca2þ current types (Fig. 1Ca and Cb) as compared to control
cells. Moreover, the voltage eliciting the maximal peak current size
was positively shifted of about 5 and 10 mV for ICa,T and ICa,L,
respectively (Table 1). Therefore, melatonin was able to shift the
voltage dependence of ICa,T and ICa,L towards positive potentials.
Then, the mean peak current value estimated in all the
experiments done was plotted vs. voltage (Fig. 2A). The analysis
of the Boltzmann curves fitted to the normalized I–V data for
activation and inactivation of both Ca2þ currents types (Fig. 2B
and C), shows that melatonin positively shifted the Va values for
ICa,T and ICa,L activation of about 5 and 10 mV, respectively
(Table 1). In contrast, we did not observe any significant shift of
Vh neither for ICa,T or ICa,L.
ICa,L steady-state inactivation showed an U-shaped curve. Nota-
bly, the decaying branch at negative potentials was not affected by
melatonin, but that at positive potentials was reduced (Fig. 2C).
Interestingly, by analysing the best fit to the resulting I–V
curves we could clearly observe that the reversal potential was
positively shifted in both the current types in a similar amount
of about 8 mV (Fig. 2Aa and Ab, showed in detail in 2Ac;
compare red triangles and blue circles related to melatonin vs.
black symbols, related to Ctr). From the estimated value of the
ICa reversal potential resulting in melatonin-treatment, we
could suggest that melatonin may be able to induce a decrease
of free [Ca2þ]i. This assumption was confirmed by experiments
of Ca2þ imaging showing that in melatonin-treated cells the
resting [Ca2þ]i was actually reduced by about 50% with respect
to control cells (Fig. 3).
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Fig. 1. Melatonin treatment affects Ca2þ current. Typical current traces recorded in high TEA-Ca2þ solution from a control and a melatonin-treated cell after 72 h in culture
in growth medium. A) Typical total Ca2þ current traces, ICa,tot, evoked by voltage steps from 70 to 50 mV in 10 mV increments (HP¼80 mV), in the absence (Aa, Ctr) and
in the presence of melatonin 100 mM (Ab, MLT). Ba) Representative family of ICa,T current traces evaluated in a control cell in the presence of nifedipine 100 mM; only the first
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3.2. Melatonin treatment affects different types of Kþ currents
in MCF-7 cells
To test melatonin effects on Kþ currents in MCF-7 cells, we
performed a detailed electrophysiological analysis. First, the
different types of Kþ currents recorded were identified by a
pharmacological dissection. After that, we performed the same
experiments on melatonin-treated cells. A representative experi-
ment related to cells cultured for 72 h in growth medium is
reported in Fig. 4: it shows an example of pharmacological
dissection of Kþ currents in a typical MCF-7 cell where only the
current response to a 50-mV pulse is displayed, either in an
untreated (Ctr) or in a melatonin-treated cell (MLT).
Representative currents elicited at any step potential are
depicted as current density in Fig. 5 and referred to IK,tot (A), IBK
(B), IKs (C) and IK(V) (D) from untreated (panels a, Ctr) and
melatonin-treated cells (panels b, MLT). It can be clearly seen that
melatonin treatment caused a reduction in IK,tot density (Fig. 5Aa
and Ab). Thanks to the pharmacological dissection (see Section 2),
we could assess that such a decrease was mostly due to the strong
decline of IBK and IK(V) current density (about 0.3 and 0.4 fold,
respectively, Fig. 5B and D). In contrast, melatonin treatment
appeared to increase IKs current density (about 1.6 fold, Fig. 5C).
The I–V plots related to all the experimental data confirmed this
conclusion (panels c).
3.3. Effect of melatonin treatment on IBK Ca
2þ-dependence
Due to the striking role likely played by IBK in MCF-7 cells cultured
in growth medium, we aimed to study in detail its Ca2þ-dependence.
Thus, to evaluate the entity of melatonin effects on IBK Ca2þ-
dependence we applied the two-pulse protocol in MCF-7 cells
(see Methods). ICa recorded by stepping the voltage to 0 mV in the
absence and presence of Cd2þ (0.8 mM) is shown in Fig. 6A. In the
absence of Cd2þ we recorded an inward current (ICa) followed by an
outward one (IBK, blue traces), that was completely blocked by Cd2þ
(red traces). The effect of Ca2þ influx on IBK was studied by pre-
pulsing the membrane potential to 0 mV (Fig. 6). When the mem-
brane potential was stepped from 0 mV to 70 mV the current traces
showed an instantaneous current (Iist) (Marcantoni et al., 2010;
Table 1
MLT affects Boltzmann parameters of ICa,T and ICa,L activation and inactivation. MLT
decreases the maximum peak size of ICa,T and ICa,L, indexes of the inhibitory effect
on these channels activity; moreover it shifts the voltage threshold and the voltage
values eliciting the maximal peak current in the I–V plots (Vp) and the Va
Boltzmann parameters of activation for both ICa,T and ICa,L towards more positive
potentials. MLT did not affect the parameters ka, kh and Vh for both ICa,T and ICa,L.
Parameters Control Melatonin
ICa,T
ICa,T/Cm (pA/pF) 1.770.18 0.570.12a
Gm/Cm (pS/pF) 21.872.00 6.271.30a
Vp (mV) 30.172.42 25.271.58b
Va (mV) 40.172.68 35.071.71c
ka (mV) 5.570.43 5.570.52
Vrev (mV) 58.072.75 61.872.78c
Vh (mV) 64.674.06 64.973.10
kh (mV) 4.570.53 4.470.42
ICa,L
ICa,L/Cm (pA/pF) 4.970.38 2.070.42a
Gm/Cm (pS/pF) 88.0714.21 36.4710.24a
Vp (mV) 0.2472.05 10.473.08a
Va (mV) 10.072.09 5.271.06a
ka (mV) 7.270.36 7.370.47
Vrev (mV) 59.072.76 68.272.73c
Vh (mV) 5573.00 52.573.02
kh (mV) 7.570.46 7.470.51
Data are mean7S.E.M. and in each experimental condition were from
n¼36⧸39 cells.
a Po0.005 respect to control (Student's t-test).
b Po0.01.
c Po0.05.
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Prakriya and Lingle 1999) followed by a slow increase in the current
size. The changes induced by conditioning steps on Ip and tp were
very small and not statistically significant respect to 5–10 ms control
test pulse (without pre-pulse). However, as long as the pre-pulse
duration increased, Ip progressively augmented (Fig. 6a), tp, evaluated
from the beginning of the 70-mV pulse, decreased (Fig. 6c) and the
time constant of the decay became faster, changing from
21070.28 ms (without pre-pulse) to 112715 ms (with 75-ms pre-
pulse). The Ip reached the maximal amplitude and the minimum tp
for 75-ms pre-pulse (Fig. 6a and c). The IBK maximal size (Ip value)
elicited by a 75-ms pre-pulse increased 1.770.2 fold (n¼7) with
respect to that evoked without the pre-pulse.
IBK was then recorded in melatonin-treated cells cultured in
growth medium for 72 h, by the two-pulse protocol and the same
recording solutions used in untreated cells. The effects on tp and
time constant of the decay time-dependence were not statistically
different from those observed in control (Fig. 6c) but the increase
of Ip amplitude was smaller as long as the pre-pulse duration
increased, reaching a quasi-steady state over 45-ms duration. In
such an interval the increment was only 1.470.2 (n¼7). The
Fig. 3. Resting [Ca2þ]i is affected by melatonin. Confocal analysis of intracellular calcium concentration. (A) MCF-7 cells were treated without (Ctr) and with melatonin (MLT)
100 mM for 72 h in growth medium. The pseudocolouring represents the absolute Ca2þ level as indicated by the color bar. (B) Fluorescence signals expressed as fractional
changes ΔF/F in control (Ctr) and melatonin-treated cells. The values are expressed as mean7S.D. of five independent experiments carried out in triplicates. nnPo0.01 of
MLT vs. Ctr.
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Fig. 4. Pharmacological dissection of Kþ currents. Typical total delayed rectifier Kþ current traces, IK,tot, (upper black trace) elicited by a voltage step to 50 mV from
HP¼60 mV in control solution (modified Normal Tyrode) with Nifedipine (10 μM) and Niþ (50 μM) in the absence (A) and in the presence of melatonin (B) recorded after
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referred to the web version of this article.)
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enhancement of Iist occurred after 25 ms in control condition and
after 45 ms under melatonin treatment. The Iist enhancement in
control was similar to Ip (1.670.2) whereas it was reduced in
melatonin-treated cells to 1.27 0.1 (Po0.05).
Finally, to test the role of ICa,T on IBK Ca2þ dependence we
blocked ICa,L with nifedipine. Since no difference was found
between IBK evaluated with and without pre-pulse (not shown),
we suggest that T-type Ca2þ channels have a marginal role, if any,
in modulating IBK channels, possibly depending on the small
amount of Ca2þ entry due to its fast transient time course and
small size, or because of their location too far from BK channels.
3.4. Melatonin affects MCF-7 cells proliferation and growth/viability
To confirm the previous finding on the effect of melatonin on
proliferation on MCF-7 cells cultured in growth medium in the
absence (control) or presence of melatonin for 72 h the nuclear
levels of Ki-67, a well-known marker of cell cycle and proliferation
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were evaluated. Once more it was confirmed that the proliferating
cells under melatonin treatment were reduced to about 40% with
respect to the untreated ones (Fig. 7A–C). To assess MCF-7 cell
growth/viability in growth medium, MTS assay revealed that
melatonin was able to induce a statistically significant decline of
growth/viability with respect to untreated cells (Fig. 8). The
selective ion channel block (Fig. 8) by Nifedipine, NiCl2, α-DTX,
IbTx, or Chr caused a slight but statistically significant inhibition of
the cell growth/viability investigated by MTS assay with respect to
control cells, indicating a significant role of the specific ion
currents ICa,L, ICa,T, IK(V), IBK and IKs in cell proliferation. The
concomitant administration of melatonin with Nifedipine, NiCl2
or IbTx did not induce significant changes with respect to control
cells. These results seem to suggest that melatonin is unable to
induce a growth/viability decrease through a pathway involving
ICa,L, ICa,T and IBK. Nevertheless, melatonin further decreased cell
growth/viability in the cells pre-treated with α-DTX or with Chr,
indicating that, even if IK(V) or IKs are blocked, it can still exert its
effect of reducing cell growth/viability. Therefore, it seems that the
further reduction observed with melatonin in the presence of
α-DTX or Chr may not strictly depend only on K(v) or Ks channels.
3.5. Effects of melatonin on Cm, resting membrane potential
and ionic currents
The effects of melatonin in proliferating MCF-7 cells cultured in
growth medium were estimated also at different culture times.
Records in normal Tyrode solution on control MCF-7 cells cultured
for 24, 48 and 72 h in growth medium showed a progressive
increase in Cm, suggesting that cells underwent an increase in cell
surface area; in contrast, in melatonin-treated cells Cm was
scarcely affected since at 72 h it showed a slight and not significant
decreased value as compared to the one observed at 24 h (Fig. 9A).
By using the current-clamp mode we also recorded the resting
membrane potential of MCF-7 cells in normal Tyrode solution
(Fig. 9B). It was observed that resting membrane potential tended
to depolarize with time in untreated cells, whereas in melatonin-
treated ones, it resulted always significantly hyperpolarized with
respect to control, although this effect was stronger at 24 and 48 h,
as compared to 72 h.
In control cells, the time-dependent increase of Cm was
paralleled by the enhancement of the maximal values of current
density and total current amplitudes of IBK, IKs and IK(V) (Fig. 9C–E)
and of Ca2þ currents (ICa,T and ICa,L) (Fig. 9F and G). The effects of
melatonin treatment on the various types of ion currents accord-
ing to the culture time were similar. In fact, the time dependent
enhancement was generally reduced and the total current values
were decreased with respect to those observed in control. A
similar trend was observed for Ca2þ current density. Except for
Ks, melatonin did not affect the current density and total current
amplitudes recorded at 24 h, showing the same mean size as in
control, but it strongly decreased the ionic currents at 48 h and
even more at 72 h (Fig. 9E G). Differently, IKs current density in the
presence of melatonin was larger than control and increased with
time in culture (Fig. 9Da). Moreover, Ks was the only component
whose total current was increased in time in the presence of
melatonin (Fig. 9Db), although its size was lesser than Ctr. This
indicates that melatonin effect observed on IKs density was
essentially related to the decrease of Cm.
3.6. Effects of melatonin on cells cultured in differentiation medium
To verify whether the effect of melatoninwas expressing solely on
proliferating cells, parallel experiments in MCF-7 cells cultured in
differentiation medium, namely DMEM supplemented with a low
serum concentration (FBS 2%). MTS assay to detect growth/viability
Fig. 7. Effects of melatonin on MCF-7 cell proliferation. Cells cultured in the absence (control) or presence of melatonin (MLT) 100 mM for 72 h in growth medium (A and B,
respectively). Cell proliferation estimated with polyclonal anti-Ki67 antibodies (green). C) The percentage of proliferating cells showing positive staining for Ki-67 nuclear
antigen is shown in the histograms in control and melatonin-treated conditions. Values are expressed as mean7S.D. of five independent experiments carried out in
triplicates. nPo0.05 MLT vs. Ctr. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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in MCF-7 cells cultured in differentiation medium (Fig. 8) revealed, as
expected, a moderate reduction of cell growth/viability compared to
the cells maintained in growth medium (indicated as Ctr in Fig. 8).
The addition of melatonin significantly reduced growth/viability in
differentiating cells, but its effect, in terms of variability reduction
was less marked than that exerted on the cells cultured in growth
medium (Ctr) suggesting that melatonin as a more marked effect on
proliferation rather than on differentiation. After 72 h in culture, cells
grown in differentiation medium (n¼22) showed a smaller Cm as
compared to control (Fig. 9A, filled diamond), indicating a decrease in
surface area with respect to 24 h. The presence of melatonin (n¼20)
elicited an opposite effect, inducing a Cm increase (open diamond) vs.
melatonin treatment in growth medium (open circles). However, this
increase in cell surface area did not differ significantly from Cm value
estimated in untreated cells after 24 h in growth medium (filled
circle). Moreover, differentiating cells also showed a hyperpolarized
resting membrane potential, typical of cells with slow proliferation
rate; melatonin caused a further hyperpolarization (Fig. 9B, filled and
open diamond, respectively).
The electrophysiological records performed on MCF-7 cells
cultured for 72 h in differentiation medium (filled diamond),
showed a reduction of the total current size of all the delayed
rectifying outward currents (IBK, IKs, IK(V)) with respect to those
cultured in growth medium at the same time (Fig. 9Cb, Db, and Eb,
compare filled diamond with filled circles at 72 h). Thus, it can
reasonably suggested that these currents have a prevalent role in
proliferation. This effect was accompanied by a slight reduction of
the calculated current density except for IKs that, in contrast,
showed an increase (Fig. 9Ca, Da, and Ea, filled diamond). Similarly,
the current density of ICa,T and ICa,L was strongly augmented
(Fig. 9Fa and Ga), whereas the related total currents amplitudes
were slightly increased after 72 h (Fig. 9Fb and Gb) with respect to
cells grown in growth medium, thus suggesting a role for these
channels also in differentiation.
Upon melatonin treatment, the total current values of IBK and IKs
recorded from cells in differentiation medium (Fig. 9Cb and Db,
open diamond) were not significantly different respect to those
observed at the same time in growth medium (open circles). By
contrast, differently to what observed in growth medium, the total
current values of IK(V) (Fig. 9Eb) as well as ICa,T and ICa,L (Fig. 9Fb and
Gb) were increased. Since the mean total current amplitude of IBK,
ICa,T and ICa,L in the presence of melatonin in 2% FCS medium was
definitely lower than that detected in untreated cells (compare
open and filled diamonds in Fig. 9Cb, Fb and Gb). Since IKs and IK(V)
showed similar values in the presence or absence of melatonin in
differentiation medium (compare open and filled diamonds in
Fig. 9Db and Eb) it appears reasonable that melatonin has not
detectable effects on these channels in the course of differentiation,
but only upon proliferation. A similar effect was observed also on
IK(V) current density where only a slight reduction could be seen
(Fig. 9Ea), whereas IKs current density was sharply decreased
(Fig. 9Da). AS for the current density of all other ion currents IBK,
IKs, ICa,T and ICa,L melatonin caused a significant decrease with
respect to untreated cells (Fig. 9Ca, Da, Fa, and Ga) suggesting that
melatonin may affect these channels functionality also in the
process of differentiation.
4. Discussion
Different types of human cancers display a peculiar biophysical
profile and/or atypical ionic channels activity. This is the reason
why the role of ionic channels in the control of the cell cycle in
normal and transformed cells has already been addressed by many
research groups, in the attempt of identifying efficient targets for
therapeutic approaches (Abdul et al., 2003; Arcangeli et al., 2009;
Asher et al., 2010; Aydar et al., 2009; Becchetti, 2011; Currò, 2014;
Wang, 2004). The detailed electrophysiological analysis performed
in this study on MCF-7 cells adds new insights to the elucidation of
the possible mechanisms involved in the oncostatic action of
melatonin based on the cultured condition. Particularly, MCF-7
cells cultured for 72 h in growth medium had a reduced surface
area, were more depolarized, and had a reduced ICa,T and ICa,L, a
greater IKs and a similar IK(V) and IBK current density respect to
MCF-7 cells cultured in differentiation medium.
The increase of the membrane depolarization, of the membrane
surface and of all the voltage-dependent Ca2þ and Kþ currents
observed in the present study in control cells in growth medium
suggests a progressive increase in the expression/activity of these
channels along with culture time. This event can successfully main-
tain the proliferative potential of MCF-7 cells that is, one of the
alarming features of the cancerous phenotype. When the cells were
cultured in growth medium in the presence of melatonin, a sig-
nificant reduction of proliferation and viability was observed as
§
Ctr Nif   NiCl2 -DTX         IbTx Chr FBS 2%α
Fig. 8. Effects of melatonin, alone or in combination with different Ca2þ and Kþ channel blockers, on MCF-7 cell growth/viability. MCF-7 cells, cultured in growth medium
(DMEM supplemented with 10% FBS, Ctr), for 72 h were not treated (untreated) or treated with melatonin, 100 mM (MLT treated) and evaluated by MTS assay without or with
the following channel blockers: nifedipine (10 mM) and NiCl2 (50 mM) for L- and T-type Ca2þ channels, respectively; α-DTX (10 nM) for K(V); IbTx (100 nM) for BK and Chr
(50 mM) for Ks channels. Last pair of bars: cells were cultured in differentiation medium, that is DMEM supplemented with 2% FBS for 72 h. Values are expressed as mean7S.
D. of five independent experiments carried out in triplicates. Optical density (O.D.) expressed in arbitrary units (a.u.). nPo0.05 channel blockers in untreated vs. control;
§Po0.05 FBS 2% vs. Ctr10%; 1Po0.05 MLT treated vs. related untreated.
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compared to untreated ones. Actually, melatonin was able to reduce
proliferation also in differentiating cells, but since this effect was less
marked than that observed in cells cultured in growth medium a
more effective action of melatonin on growth rather than on
differentiation can be suggested. To verify this hypothesis the
possible effects of melatonin on the different ion currents known
to have a role in proliferation were tested.
In relation to ICa, our findings demonstrate that melatonin
treatment was able to reduce both T- and L-type Ca2þ current
amplitude and to provoke an alteration of the current voltage
dependence along with a decrease of intracellular Ca2þ concentra-
tion. Since Ca2þ seems to be a crucial regulator of the cell cycle
necessary for proper proliferation (Bertolesi et al., 2002; Gray et al.,
2004; Naziroğlu et al., 2012; Wang et al., 2000), the associated
reduction of free [Ca2þ]i observed in our experiments supports the
clue that melatonin may contribute to the decline of proliferation
also disturbing internal Ca2þ homeostasis. The G-protein-coupled
melatonin MT1 receptors are expressed in MCF-7 cells (Girgert et al.,
2009; Hill et al., 2011b; Jablonska et al., 2013; Jawed et al., 2007; Rich
et al., 1999) and, via the inhibition of adenylate cyclase activity
(Jablonska et al., 2013; Jawed et al., 2007), their activation leads to the
decrease of adenosine 30, 50-cyclic monophosphate (cAMP) synthesis.
Considering that in MCF-7 melatonin affected cell functionality by a
significant depletion of ATP levels (Margheri et al., 2012), we propose
that the decrease of cAMP, leading to a decrease of PKA activity and
channel phosphorylation, can be considered a crucial mechanism
involved in the reduction of L-and T-type Ca2þ currents (Mahapatra
et al., 2012; Novara et al., 2004; Sundelacruz et al., 2009), further
stressing the evidence that Ca2þ channels are a target by which
melatonin can modulate cell proliferation.
Similarly, in this study we demonstrated that also Kþ currents
are involved in the melatonin modulatory action of cell prolifera-
tion. Melatonin treatment caused a reduction in IK(V) and IBK but an
increase of IKs density. MTS assay showed that melatonin
decreased cell growth/viability in cells pre-treated with α-DTX
or with Chr. However, this reduction may not univocally depend
only on K(v) or Ks channels, because even if such channels are
blocked, melatonin can still exert its effect of reducing cell
proliferation/viability through a pathway involving IBK. BK channel
activation requires Ca2þ entry which, in turn, activates BK chan-
nels located in close vicinity to the Ca2þ source (Berkefeld et al.,
2006; Marcantoni et al., 2010). According to Berkefeld et al. (2006)
and Marcantoni et al. (2010), our results on IBK could be explained
suggesting that melatonin was able to cause the shift of BK
channels far from L-type Ca2þ channels, leading to the impair-
ment of BK channels assembly and functionality and thus to the
reduction of IBK and its kinetics.
The depolarization of resting membrane potential is usually
detected in proliferating cells and, since there is a clear correlation
between resting membrane potential and mitotic activity, it is
obvious that the maintenance of a proper membrane potential
during cell cycling, mainly controlled by Kþ channels (Klimatcheva
and Wonderlin, 1999), is of primary importance. The mean resting
membrane potential values recorded in MCF-7 cells were quite
depolarized, as typically observed in cancer cells with respect to that
of terminally differentiated cells (Sundelacruz et al., 2009) and
tended to depolarize further with time in culture. Whatever the
mechanism underlying the establishment and the maintenance of
resting membrane potential in cells cultured in growth medium, it
can be affirmed that melatonin was capable to hyperpolarize the
resting membrane potential which, conversely tended to depolarize
with time in control condition. The hyperpolarization induced by
melatonin can be partly justified by the L-type Ca2þ current decrease
in amplitude, the increase of [Ca2þ]i and of IKs density.
However, to elucidate this issue, it must be considered that
besides the voltage dependent ion channel activation, many other
mechanisms may contribute to the establishment of resting
membrane potential, such as stretch activated channels (Aydar
et al., 2009; Formigli et al., 2007; Sbrana et al., 2008), ionic pumps
(2Na/3 K ATPase and Ca2þ pump), 3Na/Ca exchanger (Becchetti
2011) and voltage-independent channels as IKCa and KATP (Abdul
et al., 2003; Blackiston et al., 2009; Haren et al., 2010; Klimatcheva
and Wonderlin, 1999), and that the complexity of the scenario
requires further investigations.
Moreover, melatonin reduced the increase of Cm that is usually
observed in untreated-cells with time in culture. Therefore, we
suggest that the increase of cell membrane surface area usually
observed in control proliferating cells was definitely inhibited by
melatonin, this effect being specifically addressed to cells in prolif-
eration. In fact, when cells were cultured in differentiation medium,
melatonin caused an increase in Cm. Moreover, data obtained by MTS
assay showed that melatonin had a lower effect in reducing growth/
viability in cells cultured in differentiation with respect to growth
medium. Consequently, melatonin action differed according to the
culture media and associated proliferation rate.
5. Conclusions
Our research shows that the alteration in ion channel gating
may be considered as a final effector of the action of melatonin on
cell proliferation. Even if this is just an in vitro study, it extends
and provides novel experimental evidence related to the melato-
nin oncostatic action. In fact, the present findings indicate that
melatonin is able to counteract proliferation as well as differentia-
tion in MCF-7 cell line. This result strongly indicates that melato-
nin, as a modulator of different voltage-dependent ion channels,
might act as a new promising tool for specifically disrupting cell
viability and differentiation pathway in tumour cells and conse-
quently may be potentially helpful in cancer therapy.
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